Journal
DIABETES & METABOLISM
Volume 47, Issue 6, Pages -Publisher
MASSON EDITEUR
DOI: 10.1016/j.diabet.2021.101268
Keywords
Adiponectin; Diabetes; Inflammation; Leptin; Obesity; SARS-CoV-2
Categories
Funding
- IRCCS San Raffaele Hospital
- Italian Ministero della Salute [COVID-2020-12371617]
- EHA
- European Foundation for the Study of Diabetes Mentorship Programme 2019
Ask authors/readers for more resources
In this study, the Adpn/Lep ratio was found to be significantly different among COVID-19 patients of varying severity, and it was positively correlated with systemic inflammation, indicating a compensatory response mechanism. Patients with higher Adpn/Lep ratios were associated with better health conditions and lower mortality rates.
Aim: Obesity is a risk factor for COVID-19, but the underlying mechanisms are unclear. We investigated the role of adiponectin (an anti-inflammatory adipokine), leptin (a pro-inflammatory adipokine) and their ratio (Adpn/Lep) in this context. Design: Single-centre, prospective observational study. Methods. Adiponectin and leptin were measured in 60 COVID-19 patients with mild (not hospitalised, n=11), moderate (hospitalised but not requiring intensive care, n=25) and severe (admission to the intensive care unit [ICU] or death, n=24) disease. Results: Adiponectin and leptin levels were similar across severity groups, but patients with moderate severity had the highest Adpn/Lep ratio (1.2 [0.5; 2.0], 5.0 [1.6; 11.2], 2.1 [1.0; 3.6] in mild, moderate and severe disease; P = 0.019). Adpn/Lep, but not adiponectin or leptin alone, correlated with systemic inflammation (C reactive protein, CRP: Spearman's rho 0.293, P = 0.023). When dividing patients into Adpn/Lep tertiles, adiponectin was highest, whereas leptin was lowest in the third (highest) tertile. Patients in the highest Adpn/Lep tertile had numerically lower rates of obesity, diabetes and hypertension, and lower rates of death or admission to ICU versus other tertiles. At linear regression in the whole cohort, CRP significantly predicted Adpn/Lep (beta 0.291, P = 0.022), while female gender (beta -0.289, P = 0.016), diabetes (beta -0.257, P = 0.028), and hypertension (beta -239, P = 0.043) were negative predictors. Conclusions: We speculate that the rise in Adpn/Lep, due to increased adiponectin and reduced leptin, is a compensatory response to systemic inflammation. In patients with worse cardiometabolic health (e.g. diabetes, hypertension) this mechanism might be blunted, possibly contributing to higher mortality. (C) 2021 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available